iifl-logo

Sanjivani Paranteral Ltd Share Price

220.05
(-2.85%)
May 9, 2025|03:06:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open206.2
  • Day's High225
  • 52 Wk High396.95
  • Prev. Close226.5
  • Day's Low206
  • 52 Wk Low 167.25
  • Turnover (lac)14.25
  • P/E37.56
  • Face Value10
  • Book Value29.09
  • EPS6.03
  • Mkt. Cap (Cr.)261.46
  • Div. Yield0
View All Historical Data
No Records Found

Sanjivani Paranteral Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

206.2

Prev. Close

226.5

Turnover(Lac.)

14.25

Day's High

225

Day's Low

206

52 Week's High

396.95

52 Week's Low

167.25

Book Value

29.09

Face Value

10

Mkt Cap (₹ Cr.)

261.46

P/E

37.56

EPS

6.03

Divi. Yield

0

Sanjivani Paranteral Ltd Corporate Action

26 Dec 2023

12:00 AM

EGM

arrow

6 Aug 2024

12:00 AM

AGM

Announcement Date: 06 Aug, 2024

arrow

7 Aug 2024

12:00 AM

BookCloser

arrow

30 Jan 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Sanjivani Paranteral Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sanjivani Paranteral Ltd SHAREHOLDING SNAPSHOT

09 May, 2025|03:22 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 28.87%

Foreign: 0.00%

Indian: 28.87%

Non-Promoter- 6.16%

Institutions: 6.15%

Non-Institutions: 64.97%

Custodian: 0.00%

Share Price

Sanjivani Paranteral Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

13.71

10

10

8.5

Preference Capital

0

0

0

0

Reserves

14.19

-13.07

-17.58

-53.39

Net Worth

27.9

-3.07

-7.58

-44.89

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

25.09

16.35

17.95

32.66

yoy growth (%)

53.46

-8.92

-45.02

-71.71

Raw materials

-14.8

-9.06

-25.38

-28.15

As % of sales

58.98

55.43

141.36

86.19

Employee costs

-2.49

-2.61

-2.96

-2.77

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

1.41

-1.8

-53.37

-26.41

Depreciation

-0.85

-1.07

-1.19

-1.19

Tax paid

0

0.1

0.31

0.19

Working capital

2.96

8.78

-54.83

-23.02

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

53.46

-8.92

-45.02

-71.71

Op profit growth

-744.32

-99.36

124.45

321.48

EBIT growth

-233.46

-97.82

144.81

251.42

Net profit growth

-183.08

-96.78

102.35

79.09

View Ratios
Particulars (Rupees in Crores.)Mar-2024

Gross Sales

54.41

Excise Duty

0

Net Sales

54.41

Other Operating Income

0

Other Income

0.52

Sanjivani Paranteral Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,766.2

134.524,23,770.541,181.050.765,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,958.35

76.31,58,175.475940.52,297513.62

Cipla Ltd

CIPLA

1,486.75

25.81,20,075.941,438.150.874,134.87360.72

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183

59.051,07,722.354850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,434.1

51.931,00,425.74416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Sanjivani Paranteral Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Ashwin Khemka

Independent Director

Mrunmai M Sarvankar

Independent Director

Monika Singhania

Executive Director

Srivardhan Ashwani Khemka

Independent Director

Abhay Shah

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun.Incorporated as a public limited company in Oct.94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Companys products includes oral solids, small volume parenteral and sterile powder formulations.The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.96 to part-finance the project.The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year production of liquid vials and ampules.During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hop
Read More

Company FAQs

What is the Sanjivani Paranteral Ltd share price today?

The Sanjivani Paranteral Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹220.05 today.

What is the Market Cap of Sanjivani Paranteral Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sanjivani Paranteral Ltd is ₹261.46 Cr. as of 09 May ‘25

What is the PE and PB ratio of Sanjivani Paranteral Ltd?

The PE and PB ratios of Sanjivani Paranteral Ltd is 37.56 and 7.78 as of 09 May ‘25

What is the 52 Week High and Low of Sanjivani Paranteral Ltd?

The 52-week high/low is the highest and lowest price at which a Sanjivani Paranteral Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sanjivani Paranteral Ltd is ₹167.25 and ₹396.95 as of 09 May ‘25

What is the CAGR of Sanjivani Paranteral Ltd?

Sanjivani Paranteral Ltd's CAGR for 5 Years at 102.82%, 3 Years at 66.64%, 1 Year at 23.53%, 6 Month at -27.85%, 3 Month at -24.44% and 1 Month at -4.41%.

What is the shareholding pattern of Sanjivani Paranteral Ltd?

The shareholding pattern of Sanjivani Paranteral Ltd is as follows:
Promoters - 28.87 %
Institutions - 6.15 %
Public - 64.98 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.